Evoke Pharma Inc 4
4 · Evoke Pharma Inc · Filed Sep 3, 2014
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Hill Malcolm R
Director
Transactions
- Exercise/Conversion
Common Stock
2014-09-03$0.29/sh+5,250$1,523→ 19,250 total - Exercise/Conversion
Stock Option (right to buy)
2014-09-03−5,250→ 0 totalExercise: $0.29Exp: 2017-09-13→ Common Stock (5,250 underlying)
Footnotes (2)
- [F1]Immediately exercisable.
- [F2]Not applicable.